Correction: Opportunities for and Challenges of Pulmonary Drug Delivery in the Management of Acute Exacerbations of CNS Disorders

Affiliations

¹ Department of Neurology, Comprehensive Epilepsy Center, University of Miami Miller School of Medicine, Miami, FL, 33136, USA. Kamil.detyniecki@med.miami.edu.
² Department of Neurology, University Hospital Frankfurt, Goethe-University Frankfurt, Epilepsy Center Frankfurt Rhine-Main, Frankfurt, Germany.
³ UCB, Monheim am Rhein, Germany.
⁴ UCB, 1420, Braine‑l'Alleud, Belgium.
⁵ Center for Orphan Drug Research, College of Pharmacy, University of Minnesota, Minneapolis, MN, USA.

Published Erratum

Kamil Detyniecki et al. CNS Drugs. 2025 Nov.

. 2025 Nov;39(11):1193-1194.

doi: 10.1007/s40263-025-01224-1.

¹ Department of Neurology, Comprehensive Epilepsy Center, University of Miami Miller School of Medicine, Miami, FL, 33136, USA. Kamil.detyniecki@med.miami.edu.
² Department of Neurology, University Hospital Frankfurt, Goethe-University Frankfurt, Epilepsy Center Frankfurt Rhine-Main, Frankfurt, Germany.
³ UCB, Monheim am Rhein, Germany.
⁴ UCB, 1420, Braine‑l'Alleud, Belgium.
⁵ Center for Orphan Drug Research, College of Pharmacy, University of Minnesota, Minneapolis, MN, USA.

No abstract available

Erratum for

Opportunities for and Challenges of Pulmonary Drug Delivery in the Management of Acute Exacerbations of CNS Disorders.
Detyniecki K, Strzelczyk A, Roebling R, Laloyaux C, Chanteux H, Cloyd JC. Detyniecki K, et al. CNS Drugs. 2025 Nov;39(11):1109-1138. doi: 10.1007/s40263-025-01213-4. Epub 2025 Aug 7. CNS Drugs. 2025. PMID: 40775197 Free PMC article. Review.